SUNSTONE LIFE SCIENCE VENTURES FUND II K/S 13D and 13G filings for Orphazyme A/S:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2021-02-11 4:16 pm Purchase | 2020-12-31 | 13G | Orphazyme A/S ORPHY | SUNSTONE LIFE SCIENCE VENTURES FUND II K/S | 1,789,845 5.200% | 1,789,845 (New Position) | Filing |